Hannah Chapman
Psychiatric/Mental Health · Marion, MANPI 1245858299
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,558 of the $4,357 with a category attached, or 81.7%. 14 manufacturers reported payments, led by Corium, LLC at 31.0% of the total. Reporting peaked in 2023 at $2,133 and has fallen 92.3% since, to $165 in 2025. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $29.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$1K
- AbbVie$878
- Johnson & Johnson$626
- Axsome Therapeutics, Inc.$420
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$262
- Lundbeck LLC$188
- plus $634 from 8 others
What the payments were for
- Consulting fees$1153%
- Speaking & faculty fees$57513%
- Travel & lodging$621%
- Food & beverage$3,55882%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 31 | $1,350 |
| AbbVie | 40 | $878 |
| Johnson & Johnson | 17 | $626 |
| Axsome Therapeutics, Inc. | 9 | $420 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $262 |
| Lundbeck LLC | 10 | $188 |
| Neurocrine Biosciences, Inc. | 9 | $157 |
| Sunovion Pharmaceuticals Inc. | 7 | $114 |
| Indivior Inc. | 6 | $112 |
| Neuronetics, Inc. | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Alkermes, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Braeburn Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,357 in reported general payments places this provider in the 90th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluoxetine Hcl | 14 | $185 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Marion
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
- Kevin NardoneWorcester$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.